Correlation of Point-of-Care ecarin clotting time versus activated clotting time with bivalirudin concentrations - 28/08/11
Doi : 10.1016/S0002-9149(03)00159-0
Leslie Cho, MD a, Kandice Kottke-Marchant, MD, PhD b, A.Michael Lincoff, MD c, Marco Roffi, MD d, Joel P Reginelli, MD c, Theresa Kaldus, MT b, David J Moliterno, MD c, ⁎ 
a Department of Cardiology, Loyola University Medical Center, Maywood, Illinois, USA
b Department of Clinical Pathology, Cleveland, Ohio, USA
c Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, Cleveland, Ohio, USA
d the Division of Cardiology, University Hospital, Zurich, Switzerland This study was supported by PharmaNetics, Incorporated, Morrisville, North Carolina.
*Dr. Moliterno’s address is: Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, 9500 Euclid Avenue, F-25, Cleveland, Ohio 44195, USA.
© 2003
Excerpta Medica Inc. Tous droits réservés.
Vol 91 - N° 9
P. 1110-1113 - mai 2003 Retour au numéro
Article précédent
- Association between short-term simvastatin therapy before coronary artery bypass grafting and postoperative myocardial blood flow as assessed by positron emission tomography
- M.Imran Dotani, Anthony P. Morise, Reyaz Haque, Abnash C. Jain, Naresh Gupta, C.Michael Gibson
- Feasibility and efficacy of tandem positioning on angiographic and clinical outcomes in the Intimal Hyperplasia Inhibition With Beta In-Stent Trial
- Kazuyuki Shirai, Alexandra J. Lansky, Gary S. Mintz, Costantino O. Costantini, Ecatarina Cristea, Martin Fahy, Lynn Vandertie, Alan Yeung, Albert E. Raizner, Ron Waksman, Martin B. Leon
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?